Bain Capital Life Sciences Investors

Latest statistics and disclosures from Bain Capital Life Sciences Investors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Bain Capital Life Sciences Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Bain Capital Life Sciences Investors

Companies in the Bain Capital Life Sciences Investors portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Springworks Therapeutics (SWTX) 33.2 $528M 7.3M 72.52
Atea Pharmaceuticals (AVIR) 14.7 $235M NEW 5.6M 41.78
Arcutis Biotherapeutics (ARQT) 7.0 $112M 4.0M 28.13
Mersana Therapeutics (MRSN) 5.8 $92M 3.4M 26.61
Annexon (ANNX) 5.1 $81M 3.2M 25.03
Dicerna Pharmaceuticals (DRNA) 4.3 $68M -24% 3.1M 22.03
Syros Pharmaceuticals (SYRS) 3.9 $63M NEW 5.8M 10.85
C4 Therapeutics Com Stk (CCCC) 3.4 $54M NEW 1.6M 33.13
Solid Biosciences (SLDB) 3.4 $54M +82% 7.1M 7.58
Dynavax Technologies Corp option 3.0 $49M NEW 11M 4.45
Nurix Therapeutics (NRIX) 2.7 $42M 1.3M 32.88
Constellation Pharmceticls I (CNST) 2.5 $40M 1.4M 28.80
Aptinyx (APTX) 1.9 $31M +59% 8.9M 3.46
Kymera Therapeutics (KYMR) 1.9 $30M -34% 480k 62.00

Setup an alert

Bain Capital Life Sciences Investors will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Aeglea Biotherapeutics (AGLE) 1.3 $21M 2.7M 7.87
Marinus Pharmaceuticals 1.1 $18M 1.4M 12.20
Crinetics Pharmaceuticals In (CRNX) 0.9 $15M 1.1M 14.11
Therapeutics Acquisition Cor Com Cl A (RACA) 0.9 $14M 1.0M 13.92
Arya Sciences Acquisition Corp Iii Com Cl A (ARYA) 0.7 $11M 1.0M 10.85
X4 Pharmaceuticals (XFOR) 0.7 $11M 1.6M 6.43
Savara (SVRA) 0.4 $5.9M 5.1M 1.15
Bctg Acquisition Corp (BCTG) 0.4 $5.7M 500k 11.44
Bcls Acquisition Corp Com Cl A (BLSA) 0.3 $5.4M NEW 488k 11.14
Frazier Lifesciences Acquisition Corp Unit 12/09/2025 (FLACU) 0.2 $3.1M NEW 300k 10.38
Jiya Acquisition Corp Com Cl A (JYAC) 0.2 $3.1M NEW 300k 10.30
Helix Acquisition Corp Com Cl A (HLXA) 0.2 $2.8M NEW 250k 11.37

Past Filings by Bain Capital Life Sciences Investors

SEC 13F filings are viewable for Bain Capital Life Sciences Investors going back to 2017